| Last Price | 14.90 | Max Price | 28.85 |
| Min Price | 14.90 | 1 Year return | -40.78 |
| Avg. Target | 24.15 | Expected Return | 61.00 % |
| Sector | Health Care | Subsector | Pharmaceuticals |
| Sell | 0 | Rating |
![]() ![]() ![]()
|
| Hold | 1 | Concensus |
|
| Buy | 1 |
Contact info:Country: Germany
| Year | Turnover | Total sector | Market share |
|---|---|---|---|
| 2019 | 0 | 474,848 | 0.00 % |
| 2020 | 584 | 469,560 | 0.12 % |
| 2021 | 649 | 566,739 | 0.11 % |
| 2022 | 821 | 640,095 | 0.13 % |
| 2023 | 899 | 590,728 | 0.15 % |
| Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
|---|---|---|---|---|---|
| December 08, 2025 | Barclays | Schott Pharma | Hold | 15.00 | |
| November 03, 2025 | DZ Bank | Schott Pharma | Buy | 24.00 | 37.50 % |
| August 12, 2025 | Jefferies & Co. | Schott Pharma | Hold | 24.30 | 38.27 % |
| November 28, 2024 | UBS | Schott Pharma | Hold | 32.60 | 42.02 % |
| November 28, 2024 | Barclays | Schott Pharma | Buy | 27.00 | 30.00 % |
| September 02, 2024 | Jefferies & Co. | Schott Pharma | Hold | 31.80 | 28.62 % |
| September 01, 2024 | UBS | Schott Pharma | Hold | 32.60 | 27.91 % |
| July 09, 2024 | Barclays | Schott Pharma | Buy | 30.00 | 5.00 % |
| July 09, 2024 | Berenberg | Schott Pharma | Buy | 32.00 | 10.94 % |
| July 09, 2024 | UBS | Schott Pharma | Buy | 32.60 | 12.58 % |
| July 04, 2024 | Jefferies & Co. | Schott Pharma | Hold | 32.70 | 12.84 % |
No Records Found
No Records Found
No Records Found
| Results |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Revenue |
|
|
|
|
|
| Costs |
|
|
|
|
|
| Profit |
|
|
|
|
|
| Margin of profit |
|
|
|
|
|
| ROI |
|
|
|
|
|
| Balance |
2021
|
2022
|
2023
|
2024
|
2025
|
|---|---|---|---|---|---|
| Equity |
|
|
|
|
|
| Debt |
|
|
|
|
|
| Total assets |
|
|
|
|
|
| Solvency |
|
|
|
|
|
| Cash |
|
|
|
|
|
| Cashflow |
|
|
|
|
|
| Employees |
|
|
|
|
|
| Revenue per employee |
|
|
|
|
|
| Cashflow / Debt |
|
|
|
|
|
| Details |
2016
|
2017
|
2018
|
2019
|
2020
|
|---|---|---|---|---|---|
| Price |
0.0
|
0.0
|
0.0
|
0.0
|
15.14
|
| Eps |
0.0
|
0.0
|
0.0
|
0.0
|
0.51
|
| Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
29.69
|
| Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
| Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
| Book value |
0.0
|
0.0
|
0.0
|
0.0
|
2.09
|
| Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
0.14
|
| Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
0.69
|
| Stocks |
0
|
0
|
0
|
0
|
151
|
| Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
2.280.31
|
|
Date
|
Price
|
|---|---|
|
17 Dec 2025
|
14.90
|
|
16 Dec 2025
|
15.00
|
|
15 Dec 2025
|
15.14
|
|
11 Dec 2025
|
15.80
|
|
10 Dec 2025
|
15.58
|
|
09 Dec 2025
|
15.84
|
|
04 Dec 2025
|
18.28
|
|
03 Dec 2025
|
18.70
|
|
27 Nov 2025
|
18.90
|
|
26 Nov 2025
|
18.70
|
|
22 Nov 2025
|
18.44
|
|
20 Nov 2025
|
18.10
|
|
19 Nov 2025
|
18.12
|
|
18 Nov 2025
|
18.12
|
|
17 Nov 2025
|
18.34
|
|
15 Nov 2025
|
19.00
|
|
13 Nov 2025
|
18.94
|
|
12 Nov 2025
|
18.86
|
|
11 Nov 2025
|
17.92
|
|
06 Nov 2025
|
18.22
|
|
05 Nov 2025
|
18.98
|
|
04 Nov 2025
|
19.00
|
|
29 Oct 2025
|
19.68
|
|
23 Oct 2025
|
20.10
|
|
18 Oct 2025
|
19.90
|
|
09 Oct 2025
|
20.55
|
|
03 Oct 2025
|
21.80
|
|
30 Sep 2025
|
21.00
|
|
22 Sep 2025
|
21.70
|
|
16 Sep 2025
|
21.65
|